Cite
HARVARD Citation
Wu, L. et al. (2017). MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development. Hepatology research. 47 (1), pp. 80-94. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, L. et al. (2017). MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development. Hepatology research. 47 (1), pp. 80-94. [Online].